91
90
Growth Score
32 pts
Heat Score
89 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
4267248
Terasom develops exosome-based diagnostics, immunotherapy vaccines, and regenerative medicine for lung cancer and other solid tumors.
About the Company
Terasom develops exosome-based biomedical products focused on lung cancer and other solid tumors. The company works on exosome-based liquid biopsy diagnostics to enable rapid detection of early and metastatic lung cancer. It develops immunotherapy vaccines that harness the immune system to prevent solid tumour formation and to support treatment
across cancer stages. Terasom also researches exosome-based regenerative medicine intended to repair damaged lung tissue. Its platform integrates diagnostics, prevention, treatment, and regeneration to support the full course of a patient’s disease journey.
